References
- Huch M. Regenerative biology: the versatile and plastic liver. Nature. 2015;517(7533):155–156.
- Bonis PA, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N Engl J Med. 2001;344(6):452–454.
- Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009;50(4):1294–1306.
- van Dijk F, Hazelhoff CM, Post E, et al. Design of a gene panel to expose the versatile role of hepatic stellate cells in human liver fibrosis. Pharmaceutics. 2020;12(3):278.
- Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30(3):245–257.
- Glaser SS, Gaudio E, Miller T, et al. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med. 2009;11:e7.
- Friedman SL, Ratziu V, Harrison SA, et al. A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Hepatology. 2018;67(5):1754–1767.
- Sunami Y, Leithäuser F, Gul S, et al. Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation. Hepatology. 2012;56(3):1117–1128.
- Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397–411.
- Reyes-Escogido MdL, Gonzalez-Mondragon EG, Vazquez-Tzompantzi E. Chemical and pharmacological aspects of capsaicin. Molecules. 2011;16(2):1253–1270.
- Basu P. Euphorbia bicolor (Euphorbiaceae) latex phytochemicals induce long-lasting non-opioid peripheral analgesia in a rat model of inflammatory pain. Front Pharmacol. 2019;10:958.
- Uhelski ML, McAdams B, Johns ME, et al. Lack of relationship between epidermal denervation by capsaicin and incisional pain behaviors: a laser scanning confocal microscopy study in rats. Eur J Pain. 2020;24(6):1197–1208.,
- Lu M, Chen C, Lan Y, et al. Capsaicin-the major bioactive ingredient of chili peppers: bio-efficacy and delivery systems. Food Funct. 2020;11:2848–2860..
- Scheau C, Badarau IA, Caruntu C, et al. Capsaicin: effects on the pathogenesis of hepatocellular carcinoma. Molecules. 2019; 24(13):2350.
- Bashiri H, Hosseini-Chegeni H, Alsadat Sharifi K, et al. Activation of TRPV1 receptors affects memory function and hippocampal TRPV1 and CREB mRNA expression in a rat model of biliary cirrhosis. Neurol Res. 2018;40(11):938–947.
- Liu C, Liao JZ, Li PY. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23(11):1964–1973.
- Choi JH, Jin SW, Choi CY, et al. Capsaicin inhibits dimethylnitrosamine-induced hepatic fibrosis by inhibiting the TGF-beta1/Smad pathway via peroxisome proliferator-activated receptor gamma activation. J Agric Food Chem. 2017;65(2):317–326.
- Bitencourt S, Stradiot L, Verhulst S, et al. Inhibitory effect of dietary capsaicin on liver fibrosis in mice. Mol Nutr Food Res. 2015;59(6):1107–1116.
- Pellicoro A, Ramachandran P, Iredale JP, et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14(3):181–194.
- O’Neill J, Brock C, Olesen AE, et al. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev. 2012;64(4):939–971.
- An SY, Jang YJ, Lim H-J, et al. Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology. 2017;152(5):1174–1186.
- Yu F-X, Teng Y-Y, Zhu Q-D, et al. Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis. Biochem Cell Biol. 2014;92(5):406–412.
- Zhangdi H-J, Su S-B, Wang F, et al. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol. 2019;25(33):4835–4849.
- Cai X, Wang J, Wang J, et al. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy. Pharmacol Res. 2020;155:104720.
- Moon M-Y, Kim H-J, Kim M-J, et al. Rap1 regulates hepatic stellate cell migration through the modulation of RhoA activity in response to TGFβ1. Int J Mol Med. 2019;44(2):491–502.
- Xu J, Chi F, Tsukamoto H. Notch signaling and M1 macrophage activation in obesity-alcohol synergism. Clin Res Hepatol Gastroenterol. 2015;39 Suppl 1(Suppl 1):S24–S28.
- Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
- Barcena-Varela M, Colyn L, Fernandez-Barrena MG. Epigenetic mechanisms in hepatic stellate cell activation during liver fibrosis and carcinogenesis. Int J Mol Sci. 2019;20(10).
- Hu H-H, Chen D-Q, Wang Y-N, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76–83.
- Chen S, Wang H, Su Y, et al. Mesenchymal stem cell-laden, personalized 3D scaffolds with controlled structure and fiber alignment promote diabetic wound healing. Acta Biomater. 2020;108:153–167.
- Tsao P-N, Wei S-C, Huang M-T, et al. Lipopolysaccharide-induced Notch signaling activation through JNK-dependent pathway regulates inflammatory response. J Biomed Sci. 2011;18:56.